| EARNINGS PER SHARE Basic and diluted earnings per share were calculated as follows: | | | | | | | | | | | | | | | | | Three months ended March 31, | | | | 2026 | | 2025 | | | | | | Numerator: | | | | | | | | | | | | | | | | | Net income attributable to The Vita Coco Company, Inc. | $ | 30,474 | | | $ | 18,882 | | | | | | | Denominator: | | | | | | | | | Weighted-average number of common shares used in earnings per share—basic | 57,114,475 | | | 56,994,146 | | | | | | Effect of conversion of stock options and RSUs | 3,356,849 | | | 2,981,681 | | | | | | | Weighted-average number of common shares used in earnings per share—diluted | 60,471,324 | | | 59,975,827 | | | | | | | Earnings per share—basic | $ | 0.53 | | | $ | 0.33 | | | | | | | Earnings per share—diluted | $ | 0.50 | | | $ | 0.31 | | | | | |
The following potentially dilutive securities, prior to the use of the treasury stock method, have been excluded from the computation of diluted weighted-average number of common shares outstanding, as they would be anti-dilutive: | | | | | | | | | | | | | | | | | Three months ended March 31, | | | | 2026 | | 2025 | | | | | | Stock options and restricted stock awards | — | | | 169,720 | | | | | |
|